Indications in melanoma trials that tumor PD-L1 expression, density of TILs, and proportion of T cells expressing PD-1 or PD-L1 was associated with response led to the categorization schema outline above in an attempt to identify subsets of melanoma patients who would be most likely to respond to treatment (Table 1) [3, 9]. Here, CD274 is linked to melanoma.